ASH 2020 – Focused on Diffuse Large B-Cell Lymphoma

Socioeconomic Disparities Impact Access to Care for Patients with DLBCL

Socioeconomic Disparities Impact Access to Care for Patients with DLBCL

Guidelines from the World Health Organization and National Comprehensive Cancer Network recommend that all patients with diffuse large B-cell lymphoma (DLBCL) receive immunohistochemistry (IHC)...
T-cells attacking cancer cell

Effects of a Dual-Targeting CD19/22 CAR T-Cell Therapy in Combination with Pembrolizumab for DLBCL

AUTO3 is a chimeric antigen receptor (CAR) T-cell targeting CD19/22 with limited duration of PD-1 blockade. A study presented at the 2020 ASH Annual...

Renal Function Does Not Impact Efficacy of Selinexor in Patients with DLBCL

A study presented at the 2020 ASH Annual Meeting found that the efficacy of selinexor in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL)...
Doctor showing digital tablet to male patient lying on bed. Man is with healthcare worker in ICU. They are at hospital during COVID-19.

Can an MRD Assay Better Predict DLBCL Disease Progression?

Researchers assessed the use of a next-generation sequencing (NGS)-based minimal residual disease (MRD) assay for early detection of molecular relapse in diffuse large B-cell...
Nurse interacting with patient

Which of These Treatment Combinations Extend Survival for DLBCL?

A real-world study presented at the 2020 ASH Annual Meeting observed no significant survival differences in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL)...

Recent Hematology and Oncology Headlines

Hypofractionated, Breast Cancer Incidence Differs Among Black and White Males

Researchers Assess Trends in Myeloma Incidence and Mortality

A research team from the Division of Cancer Prevention and Control at the Centers for Disease Control and Prevention assessed recent trends in incidence...

COVID-19 Update: President-elect Biden Outlines $1.9 Trillion Coronavirus Relief Plan; Fauci Says 100 Million...

On Thursday, January 14, 2021, here are the latest COVID-19 numbers around the world, according to statistics aggregator, Worldometer.  World Cases: Over 93.8 million. ...
eligibility, ORLM, Pegilodecakin with Pembrolizumab or Nivolumab Effectively Treats Tumors

New Guidelines for Lung Cancer Improve Eligibility Among Minorities, But Don’t Close Racial Gap

An analysis of the latest US Preventive Services Task Force (USPSTF) lung cancer screening guideline for screening eligibility found that while improvements were made...

Researchers Develop Tool that Predicts Chemotherapy Toxicity in Older Adults

Researchers developed a precision medicine tool that predicts grade 3-5 chemotherapy toxicity in older adults with early-stage breast cancer. The study appeared in the...